Anaplastic thyroid carcinoma, version 2.2015 Review uri icon

Overview

MeSH Major

  • Thyroid Carcinoma, Anaplastic
  • Thyroid Neoplasms

abstract

  • This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Thyroid Carcinoma focuses on anaplastic carcinoma because substantial changes were made to the systemic therapy recommendations for the 2015 update. Dosages and frequency of administration are now provided, docetaxel/doxorubicin regimens were added, and single-agent cisplatin was deleted because it is not recommended for patients with advanced or metastatic anaplastic thyroid cancer.

authors

publication date

  • January 2015

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC4986600

PubMed ID

  • 26358798

Additional Document Info

start page

  • 1140

end page

  • 50

volume

  • 13

number

  • 9